Pharmaceuticals (155) | Compensation Agreements (155)
Browse by Company
-
ACELRX PHARMACEUTICALS INC (6)
-
Aclaris Therapeutics, Inc. (7)
-
AERIE PHARMACEUTICALS INC (1)
-
ALIMERA SCIENCES INC (1)
-
Amag Pharmaceuticals (2)
-
Amneal Pharmaceuticals, Inc. (3)
-
Amphastar Pharma (1)
-
Amylyx Pharmaceuticals, Inc. (1)
-
AN2 Therapeutics, Inc. (1)
-
Angion Biomedica Corp. (3)
-
APRICUS BIOSCIENCES, INC. (2)
-
Assertio Therapeutics, Inc (1)
-
Atea Pharmaceuticals, Inc. (2)
-
Athira Pharma, Inc. (2)
-
Biofrontera Inc. (1)
-
Blue Water Acquisition Corp. (1)
-
Bristol-Myers Squibb (1)
-
Canopy Growth Corp (2)
-
Cara Therapeutics, Inc. (3)
-
CARDAX, INC. (1)
-
Cerecor Inc. (1)
-
Clearside Biomedical, Inc. (1)
-
Clever Leaves Holdings Inc. (1)
-
CNS Pharmaceuticals, Inc. (2)
-
CymaBay Therapeutics, Inc. (1)
-
Edgewise Therapeutics, Inc. (1)
-
Endo International plc (1)
-
Evofem Biosciences, Inc. (3)
-
Evoke Pharma Inc (4)
-
EYENOVIA, INC. (1)
-
Fulcrum Therapeutics, Inc. (3)
-
Harmony Biosciences Holdings, Inc. (1)
-
Horizon Pharma plc (4)
-
Ikena Oncology, Inc. (1)
-
Intersect ENT, Inc. (2)
-
Intra-Cellular Therapies, Inc. (3)
-
Iterum Therapeutics plc (1)
-
Jazz Pharmaceuticals plc (2)
-
Journey Medical Corp (1)
-
KEMPHARM, INC (5)
-
Landos Biopharma, Inc. (1)
-
Lannett Company, Inc. (1)
-
Level Brands, Inc. (1)
-
Longboard Pharmaceuticals, Inc. (1)
-
Lyra Therapeutics, Inc. (1)
-
Merck (2)
-
Milestone Pharmaceuticals Inc. (2)
-
MJ Holdings, Inc. (1)
-
MyoKardia Inc (3)
-
Neos Therapeutics, Inc. (2)
-
Neuralstem, Inc. (1)
-
NGM BIOPHARMACEUTICALS INC (1)
-
NovaBay Pharmaceuticals, Inc. (2)
-
Novan, Inc. (3)
-
OMEROS CORP (1)
-
Pacira Pharmaceuticals, Inc. (1)
-
Panacea Acquisition Corp (2)
-
Paratek Pharmaceuticals, Inc. (3)
-
Pfizer (2)
-
Phathom Pharmaceuticals, Inc. (3)
-
PLIANT THERAPEUTICS, INC. (4)
-
ProPhase Labs, Inc. (4)
-
Rani Therapeutics Holdings, Inc. (1)
-
REATA PHARMACEUTICALS INC (4)
-
resTORbio, Inc. (1)
-
Revance Therapeutics, Inc. (5)
-
Satsuma Pharmaceuticals, Inc. (1)
-
SCYNEXIS INC (2)
-
Sienna Biopharmaceuticals, Inc. (1)
-
Strongbridge Biopharma plc (2)
-
Terns Pharmaceuticals, Inc. (3)
-
Theseus Pharmaceuticals, Inc. (1)
-
Trevi Therapeutics, Inc. (2)
-
Verrica Pharmaceuticals Inc. (2)
-
Wave Life Sciences Ltd. (3)
-
XERIS PHARMACEUTICALS INC (1)
-
ZOGENIX, INC. (1)
-
Zomedica Pharmaceuticals Corp. (1)
-
Zynerba Pharmaceuticals, Inc. (1)
Recent Contracts
-
Non-Employee Director Compensation Table
(Canopy Growth Corp, Filed With SEC on May 31, 2022)
-
Summary of Director Compensation
(Biofrontera Inc., Filed With SEC on May 24, 2022)
-
2022 Equity Compensation Plan
(ProPhase Labs, Inc., Filed With SEC on May 20, 2022)
-
2022 Directors Equity Compensation Plan
(ProPhase Labs, Inc., Filed With SEC on May 20, 2022)
-
Non-Employee Director Compensation Policy
(Novan, Inc., Filed With SEC on May 16, 2022)
-
Seventh Amended and Restated Non-Employee Director Compensation Policy
(KEMPHARM, INC, Filed With SEC on May 12, 2022)
-
Non-Employee Director Compensation Policy, as amended
(Intra-Cellular Therapies, Inc., Filed With SEC on May 10, 2022)
-
Amended and Restated Non-Employee Director Compensation Policy
(Cara Therapeutics, Inc., Filed With SEC on May 9, 2022)
-
Non-Employee Director Compensation Policy
(Panacea Acquisition Corp, Filed With SEC on May 9, 2022)
-
Aerie Pharmaceuticals, Inc. Nonqualified Deferred Compensation Plan and Adoption Agreement
(AERIE PHARMACEUTICALS INC, Filed With SEC on May 6, 2022)
